Subscribe
amelia19-shutterstock-com
Amelia19 / Shutterstock.com
4 June 2015EuropePaul England and Anja Lunze

UPC: The true meaning of opt-out

Our previous article discussed which type of patent can be litigated where in the new Unified Patent Court (UPC) system. This included the dual track—national and UPC—jurisdiction for classical European patents that will operate during the transitional period.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Patent firms unveil joint UPC ‘powerhouse’
15 November 2022   Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Big Pharma
Patent firms unveil joint UPC ‘powerhouse’
15 November 2022   Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.

More on this story

Big Pharma
Patent firms unveil joint UPC ‘powerhouse’
15 November 2022   Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’
UPC confirms validity of Edwards Lifesciences heart valve tech patent
UKIPO launches ‘revolutionary’ patent filing and AI tool
Sanofi and Regeneron triumph in UPC decision against Amgen
Most active firms at UPC revealed in report on court’s first year
Labour govt appoints new Minister with IP oversight
BlueAllele says rival gained $100m from Regeneron deal using patented tech
UPC’s second infringement decision revokes patent in Europe